BeneChill

SAN DIEGO and STOCKHOLM, June 4, 2010 - Amgen executive Alan Raffensperger has been appointed the new Chief Executive Officer of BeneChill, a privately held medical device company launching its first product, a novel cooling device for use by emergency response teams in the field, later this year in Europe.

ORLANDO, Florida, November 15 - The first randomized intra-arrest cooling study performed using a novel intra-nasal cooling method showed much faster and earlier cooling in treated patients and significantly higher neurologically intact survival - to - discharge rate in many patients.

SAN DIEGO - - 200 European Cardiac Arrest Patients in Novel Direct-To-Brain Cooling Trial - The first randomized intra-arrest cooling study has been selected for presentation as a Late Breaking trial during the American Heart Association's Scientific Sessions next month.